# Edimer Pharmaceuticals, Inc. — Form D

Edimer Pharmaceuticals, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-07. The offering totals $18.0M, of which $9.8M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-08-07
- Form: D
- Accession: 0001466103-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $18.0M
- Amount sold: $9.8M
- Remaining: $8.2M
- Investors: 5
- Date of first sale: 2013-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-200941

## Issuer

- Name: Edimer Pharmaceuticals, Inc.
- CIK: 0001466103
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 55 Cambridge Parkway, Suite 102W, Cambridge, MA, 02142
- Phone: 617-758-4300

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| William Aliski | Director | Novato, CA |
| Wendy Dixon | Director | Cambridge, MA |
| Neil Kirby | Director | Cambridge, MA |
| David Mott | Director | Chevy Chase, MD |
| Cary Pfeffer | Director | Boston, MA |
| Mitchell Bloom | Executive Officer | Boston, MA |
| Neil Kirby | Executive Officer | Cambridge, MA |

## More

- [CIK 1466103 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1466103&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001466103-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.